BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34661502)

  • 1. Prognostic impact of cN-III mRNA expression on overall survival and drug sensitivity in pediatric leukemia.
    Domenech C; Plesa A; Tourette A; Bertrand Y; Dony A; Dumontet C; Cros-Perrial E; Jordheim LP
    Leuk Lymphoma; 2022 Feb; 63(2):457-462. PubMed ID: 34661502
    [No Abstract]   [Full Text] [Related]  

  • 2. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia.
    Hollink IH; van den Heuvel-Eibrink MM; Zimmermann M; Balgobind BV; Arentsen-Peters ST; Alders M; Willasch A; Kaspers GJ; Trka J; Baruchel A; Creutzig U; Pieters R; Reinhardt D; Zwaan CM
    J Clin Oncol; 2010 Oct; 28(28):e523-6; author reply e527-e528. PubMed ID: 20644087
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
    Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Zhou JD; Yang DQ; Wang YX; Wen XM; Guo H; Yang L; Lian XY; Lin J; Qian J
    J Cell Physiol; 2018 Aug; 233(8):5838-5846. PubMed ID: 29219176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-mRNA Profiling Reveals Prognostic Impact of
    Gadewal N; Kumar R; Aher S; Gardane A; Gaur T; Varma AK; Khattry N; Hasan SK
    Oncol Res; 2020 May; 28(3):321-330. PubMed ID: 32059753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
    Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
    J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia.
    Tyagi A; Pramanik R; Bakhshi R; Singh A; Vishnubhatla S; Bakhshi S
    Int J Hematol; 2019 Aug; 110(2):205-212. PubMed ID: 31119613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of abnormally expressed, long noncoding RNAs in acute myeloid leukemia: a meta-analysis.
    Shi J; Shi X; Dai RQ
    Hematology; 2020 Dec; 25(1):219-228. PubMed ID: 33346694
    [No Abstract]   [Full Text] [Related]  

  • 10. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
    Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
    J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
    Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Zimmermann M; Peeters JK; Valk PJ; Balgobind BV; Sonneveld E; Kaspers GJ; de Bont ES; Trka J; Baruchel A; Creutzig U; Pieters R; Reinhardt D; Zwaan CM
    Haematologica; 2011 Mar; 96(3):384-92. PubMed ID: 21134981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.
    Wang J; Li F; Ma Z; Yu M; Guo Q; Huang J; Yu W; Wang Y; Jin J
    EBioMedicine; 2018 Feb; 28():90-96. PubMed ID: 29402726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
    Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM
    Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
    Becker H; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Margeson D; Whitman SP; Wu YZ; Schwind S; Paschka P; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD
    J Clin Oncol; 2010 Feb; 28(4):596-604. PubMed ID: 20026798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher lipocalin 2 expression may represent an independent favorable prognostic factor in cytogenetically normal acute myeloid leukemia.
    Yang WC; Lin PM; Yang MY; Liu YC; Chang CS; Chou WC; Hsu JF; Huang CT; Cho SF; Yu WH; Lin SF
    Leuk Lymphoma; 2013 Aug; 54(8):1614-25. PubMed ID: 23150981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia.
    Elsayed AH; Rafiee R; Cao X; Raimondi S; Downing JR; Ribeiro R; Fan Y; Gruber TA; Baker S; Klco J; Rubnitz JE; Pounds S; Lamba JK
    Leukemia; 2020 Mar; 34(3):735-745. PubMed ID: 31645648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia.
    Hu Y; Lv X; Wu Y; Xu J; Wang L; Chen W; Zhang W; Li J; Zhang S; Qiu H
    Hematology; 2015 May; 20(4):187-95. PubMed ID: 25130683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the combination of serum l-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia.
    Hara T; Matsumoto T; Shibata Y; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Nannya Y; Shimizu M; Ito H; Saito K; Tsurumi H
    Leuk Lymphoma; 2016 Sep; 57(9):2208-11. PubMed ID: 26762931
    [No Abstract]   [Full Text] [Related]  

  • 20. ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.
    Yang X; Shi J; Zhang X; Zhang G; Zhang J; Yang S; Wang J; Ke X; Fu L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.